Unknown

Dataset Information

0

Protons to Patients: targeting endosomal Na+ /H+ exchangers against COVID-19 and other viral diseases.


ABSTRACT: While there is undeniable evidence to link endosomal acid-base homeostasis to viral pathogenesis, the lack of druggable molecular targets has hindered translation from bench to bedside. The recent identification of variants in the interferon-inducible endosomal Na+ /H+ exchanger 9 associated with severe coronavirus disease-19 (COVID-19) has brought a shift in the way we envision aberrant endosomal acidification. Is it linked to an increased susceptibility to viral infection or a propensity to develop critical illness? This review summarizes the genetic and cellular evidence linking endosomal Na+ /H+ exchangers and viral diseases to suggest how they can act as a broad-spectrum modulator of viral infection and downstream pathophysiology. The review also presents novel insights supporting the complex role of endosomal acid-base homeostasis in viral pathogenesis and discusses the potential causes for negative outcomes of clinical trials utilizing alkalinizing drugs as therapies for COVID-19. These findings lead to a pathogenic model of viral disease that predicts that nonspecific targeting of endosomal pH might fail, even if administered early on, and suggests that endosomal Na+ /H+ exchangers may regulate key host antiviral defence mechanisms and mediators that act to drive inflammatory organ injury.

SUBMITTER: Prasad H 

PROVIDER: S-EPMC8646450 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC4066934 | biostudies-literature
| S-EPMC10265516 | biostudies-literature
| S-EPMC7566896 | biostudies-literature
| S-EPMC10001859 | biostudies-literature
| S-EPMC7153995 | biostudies-literature
| S-EPMC11342557 | biostudies-literature
| S-EPMC9676661 | biostudies-literature
| S-EPMC7103123 | biostudies-literature
| S-EPMC5461643 | biostudies-literature
| S-EPMC5590033 | biostudies-literature